ISSN: 1053-2498

Journal Home

Journal Guideline

Journal of Heart and Lung Transplantation Q1 Unclaimed

Elsevier USA United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Heart and Lung Transplantation is a journal indexed in SJR in Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine with an H index of 151. It has an SJR impact factor of 2,71 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,71.

Journal of Heart and Lung Transplantation focuses its scope in these topics and keywords: heart, transplantation, lung, pulmonary, disease, injury, international, allograft, arterial, survival, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Cardiology and Cardiovascular Medicine (Q1) Pulmonary and Respiratory Medicine (Q1) Surgery (Q1) Transplantation (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Journal of Heart and Lung Transplantation

2,71

SJR Impact factor

151

H Index

250

Total Docs (Last Year)

639

Total Docs (3 years)

7144

Total Refs

3906

Total Cites (3 years)

388

Citable Docs (3 years)

5.44

Cites/Doc (2 years)

28.58

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of the American College of Cardiology Q1
Circulation Q1
JAMA Cardiology Q1
Nature Reviews Cardiology Q1
European Journal of Heart Failure Q1

Compare this journals

Aims and Scope

Best articles by citations

Cardiac transplantation in patients with refractory ventricular arrhythmias11The authors wish to thank Tim Furlong for expert secretarial assistance in the preparation of this manuscript.

The significance of HLA matching in cardiac transplantation

Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration

Arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in rats

Pediatric arterio-venous extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation

Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation

Lung transplantation in a Jehovah's Witness

Selection and management of ventricular assist device patients: the Muenster experience

The effect of race on beta-adrenergic receptor density

The effect of short-term coronary perfusion using a perfusion apparatus on canine heart transplantation from non-heart-beating donors

Genetic variations of the apolipoprotein E gene determine the plasma triglyceride levels after heart transplantation

Hepatitis C transmission and infection by orthotopic heart transplantation

SHOW MORE ARTICLES

Phospholipase A2 inhibitor attenuates NOx production and myocardial damage in the cardiac allograft

Accelerated cardiac allograft rejection with apoptosis and complement deposition in Fc receptor null mice

Use of donor hearts with coronary artery disease

Behavioral and environmental factors contributing to the development and progression of congestive heart failure11The author wishes to thank Tim Furlong for excellent secretarial assistance in the preparation of this manuscript.

Who should be transplanted with HLHS? Few patient related factors alter outcome following stage I reconstruction

Sudden death in heart failure patients: effects of optimized medical therapy

IL-4 receptora gene polymorphism in heart transplantation

Reduced size lung transplantation - technique and results

Increased expression of a spliced isoform of serum response factor contributes to DYS-regulation of myocardial gene expression during heart failure

Endothelial MHC-I-peptides specificity in IFN-gamma induced cytoprotection against natural killing

Preservation of the lung with LPD solution - one year of follow up

Calcium channel blockers and angiotensin-converting enzyme inhibitors in the prevention of graft vasculopathy